Felodipine Extended Release Tablets, USP 10 mg,100-count bottle, Rx only, Distributed by: Heritag...

FDA Recall #D-0108-2021 — Class III — October 23, 2020

Recall #D-0108-2021 Date: October 23, 2020 Classification: Class III Status: Terminated

Product Description

Felodipine Extended Release Tablets, USP 10 mg,100-count bottle, Rx only, Distributed by: Heritage Pharmaceuticals Inc. East Brunswick, NJ 08816 Made in India, NDC 23155-050-01

Reason for Recall

Failed impurities/ degradation specifications: Out of specification impurity results were observed during routine testing of stability samples for the impurity Felodipine Related compound A

Recalling Firm

Heritage Pharmaceuticals Inc — East Brunswick, NJ

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

7176 bottles

Distribution

USA Nationwide

Code Information

Lot #: 18029979, Exp 1/2021

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated